Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass

Yonsei University

Status: Completed

Conditions: Mitral Valvular Heart Disease

Treatments: Drug: 6% hydroxyethyl starch 130/0.4 and 5% albumin

Study type: Interventional

Funder types: Other

Identifiers

NCT00978588

4-2007-0429

Details and patient eligibility

About

Comparison of 6% hydroxyethyl starch 130/0.4 with 5% albumin as priming solution for cardiopulmonary bypass

Enrollment: 36 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Mitral valvular heart disease

Exclusion criteria

• Status of Infection
• Re-operation
• Liver failure
• Renal disease
• Administration of steroid

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

36 participants in 2 patient groups

HES 130/0.4

Experimental group

Treatment:

Drug: 6% hydroxyethyl starch 130/0.4 and 5% albumin

5% albumin

Active Comparator group

Treatment:

Drug: 6% hydroxyethyl starch 130/0.4 and 5% albumin